80:oral Is there something special about rare diseases? Examining societal preferences for exempting orphan drugs from cost-effectiveness criteria for reimbursement
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-04-01
|
| Series: | BMJ Global Health |